SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-016649
Filing Date
2022-08-24
Accepted
2022-08-24 18:24:15
Documents
1
Period of Report
2022-08-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 6873
  Complete submission text file 0001567619-22-016649.txt   8274
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 (415) 529-5055
Imago BioSciences, Inc. (Issuer) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address IMAGO BIOSCIENCES, INC. 329 OYSTER POINT BLVD. 3RD FL SOUTH SAN FRANCISCO CA 94080
Business Address
Eichorn Laura G. (Reporting) CIK: 0001861067 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40604 | Film No.: 221192529